Resistin worsens cardiae ischaemia-reperfusion injury

被引:50
作者
Rothwell, Sarah E. [1 ]
Richards, A. Mark [1 ]
Pemberton, Christopher J. [1 ]
机构
[1] Univ Otago, Christchurch CardioEndocrine Res Grp, Dept Med, Christchurch Sch Med & Hlth Sci, Christchurch, New Zealand
关键词
ischaemia; resistin; isolated heart; TNF-alpha; NF-kappa B;
D O I
10.1016/j.bbrc.2006.08.052
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We provide the first report of direct effects of resistin upon haemodynamic and neurohumoral parameters in isolated perfused rat heart preparations. Pre-conditioning with 1 nmol L-1 recombinant human resistin prior to ischaemia significantly impaired contractile recovery during reperfusion, compared with vehicle-infused hearts (P < 0.05, n = 12). This was accompanied by a significant increase in both A-type and B-type natriuretic peptides (P < 0.05, n = 12 both ANP and BNP vs vehicle), creatine kinase, and tumour necrosis factor-a (TNF-alpha) release in resistin-infused hearts. Resistin had no significant effect on myocardial glucose uptake. Co-infusion of resistin with Bay 11 7082 (an NF-kappa B inhibitor) improved contractile recovery following ischaemia and reduced both natriuretic peptide and creatine kinase release. This is the first evidence indicating resistin impairs cardiac recovery following ischaemia, stimulates cardiac TNF-alpha secretion, and modulates reperfusion release of natriuretic peptides and biochemical markers of myocardial damage. A TNF-alpha signalling related mechanism is suggested as one component underlying these effects. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:400 / 407
页数:8
相关论文
共 39 条
[1]   Serum resistin is associated with C-reactive protein and LDL- cholesterol in type 2 diabetes and coronary artery disease in a Saudi population [J].
Al-Daghri, N. ;
Chetty, R. ;
McTernan, P. G. ;
Al-Rubean, K. ;
Al-Attas, O. ;
Jones, A. F. ;
Kumar, S. .
CARDIOVASCULAR DIABETOLOGY, 2005, 4 (1)
[2]   Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients [J].
Bajaj, M ;
Suraamornkul, S ;
Hardies, LJ ;
Pratipanawatr, T ;
DeFronzo, RA .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (06) :783-789
[3]   The transcription factor NF-κB and human disease [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (01) :3-6
[4]   Regulation of fasted blood glucose by resistin [J].
Banerjee, RR ;
Rangwala, SM ;
Shapiro, JS ;
Rich, AS ;
Rhoades, B ;
Qi, Y ;
Wang, J ;
Rajala, MW ;
Pocai, A ;
Scherer, PE ;
Steppan, CM ;
Ahima, RS ;
Obici, S ;
Rossetti, L ;
Lazar, MA .
SCIENCE, 2004, 303 (5661) :1195-1198
[5]   Resistin: molecular history and prognosis [J].
Banerjee, RR ;
Lazar, MA .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (04) :218-226
[6]   Inhibition of adipocyte differentiation by resistin-like molecule α -: Biochemical characterization of its oligomeric nature [J].
Blagoev, B ;
Kratchmarova, I ;
Nielsen, MM ;
Fernandez, MM ;
Voldby, J ;
Andersen, JS ;
Kristiansen, K ;
Pandey, A ;
Mann, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (44) :42011-42016
[7]   Resistin, an adipokine with potent proinflammatory properties [J].
Bokarewa, M ;
Nagaev, I ;
Dahlberg, L ;
Smith, U ;
Tarkowski, A .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5789-5795
[8]   Resistin expression and plasma concentration peak at different times during pregnancy in rats [J].
Caja, S ;
Martínez, I ;
Abelenda, M ;
Puerta, M .
JOURNAL OF ENDOCRINOLOGY, 2005, 185 (03) :551-559
[9]   Autocrine and paracrine actions of natriuretic peptides in the heart [J].
D'Souza, SP ;
Davis, M ;
Baxter, GF .
PHARMACOLOGY & THERAPEUTICS, 2004, 101 (02) :113-129
[10]   Serum resistin (FIZZ3) protein is increased in obese humans [J].
Degawa-Yamauchi, M ;
Bovenkerk, JE ;
Juliar, BE ;
Watson, W ;
Kerr, K ;
Jones, R ;
Zhu, QH ;
Considine, RV .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11) :5452-5455